Katja Weisel, MD of Janssen Oncology summarizes a poster presentation that focused on the anti-CD38 antibody in refractory myeloma patients which was presented at the 2017 ASCO Annual Meeting in Chicago, IL.
Annual Meeting 2017: Anti-CD38 Antibody in Refractory Myeloma Patients
